Cortical synapse

Cortical synapses are the fundamental functional units of the cerebral cortex, serving as the primary sites for communication between neurons through the release and reception of neurotransmitters (Purves et al., 2001). These structures are essential for complex cognitive processes, including learning, memory, and sensory processing, by facilitating synaptic plasticity and signal integration (Citri & Malenka, 2008). In various neurological and psychiatric conditions, such as Alzheimer's disease and schizophrenia, the progressive loss or dysfunction of these synapses is a hallmark of pathology and correlates strongly with cognitive decline (Selkoe, 2002). While the term "cortical synapse" refers to a cellular structure rather than a single molecule, it encompasses a vast array of therapeutic targets, including the NMDA receptor, GABA receptors, and synaptic vesicle proteins like SV2A (Finnema et al., 2016). Pharmacological agents often target these specific components to modulate synaptic strength, restore neurotransmitter balance, or protect against synaptic pruning. Consequently, monitoring synaptic density via biomarkers like SV2A PET imaging has become a critical tool in evaluating disease progression and drug efficacy in clinical trials (Chen et al., 2018).

Other names

Cerebral cortex synapseNeuronal synapseSynaptic junction

Drugs modulate cortical synaptic function by acting as agonists or antagonists at neurotransmitter receptors (e.g., NMDA, GABA), inhibiting neurotransmitter degradation (e.g., AChE), or binding to synaptic vesicle proteins (e.g., SV2A) to regulate neurotransmitter release probability.